SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-003079
Filing Date
2022-05-09
Accepted
2022-05-09 06:03:55
Documents
59
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insd_10q.htm   iXBRL 10-Q 914798
2 CERTIFICATION insd_ex31.htm EX-31 12852
3 CERTIFICATION insd_ex32.htm EX-32 5147
  Complete submission text file 0001477932-22-003079.txt   4378705

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA insd-20220228.xsd EX-101.SCH 53981
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE insd-20220228_lab.xml EX-101.LAB 269742
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insd-20220228_cal.xml EX-101.CAL 39719
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insd-20220228_pre.xml EX-101.PRE 213674
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insd-20220228_def.xml EX-101.DEF 83616
53 EXTRACTED XBRL INSTANCE DOCUMENT insd_10q_htm.xml XML 700889
Mailing Address 5500 NORTH SERVICE ROAD, SUITE 301 BURLINGTON A6 L7L 6W6
Business Address 5500 NORTH SERVICE ROAD, SUITE 301 BURLINGTON A6 L7L 6W6 800-542-8715
Instadose Pharma Corp. (Filer) CIK: 0001697587 (see all company filings)

IRS No.: 813599639 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 333-216292 | Film No.: 22903097
SIC: 2510 Household Furniture